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Background. A proper localisation of pathological parathyroid glands is essential for a minimally invasive approach in the surgical
treatment of primary hyperparathyroidism (PHP). The recent introduction of portable mini gamma-cameras (pMGCs) enabled
intraoperative scintigraphic scanning. The aim of our study is to evaluate the efficacy of this new method and compare it with
the preoperative localisation surveys. Methods. 20 patients were studied; they were evaluated preoperatively by neck ultrasound
and 99mmTc-sestaMIBI-scintigraphy and intraoperatively with the pMGC IP Guardian 2. The results obtained from the three
evaluations were compared. Results. The pMGC presented a sensitivity of 95%, a specificity of 98.89%, and a diagnostic accuracy of
98.18%, which were higher than those of preoperative ultrasound (sensitivity 55%; specificity 95%; diagnostic accuracy 87%) and
scintigraphy with 99mmTc-sestaMIBI (sensitivity 73.68%; specificity 96.05%; diagnostic accuracy 91.58%). Conclusions. The pMGC
can be used effectively as an intraoperative method to find the correct location of the pathological parathyroid glands. The pMGC
is more reliable than the currently used preoperative and intraoperative localisation techniques.
1. Introduction
PHP is an increasingly more frequent endocrine disorder,
being third after diabetes and thyroid disease [1].
Surgical therapy is indicated in patientswith symptomatic
PHP [2] whereas guidelines for surgical indications in
patients with asymptomatic PHPwere recently published [3].
PHP treatment has developed greatly over time, going from
bilateral cervical exploration to minimally invasive surgical
techniques [4]. This was made possible by the introduction
of, both preoperative and intraoperative, localisation tech-
niques investigations that allow the precise identification
of pathological parathyroid glands and the introduction of
the intraoperative dosage of parathyroid hormone (ioPTH)
[5, 6].
Ultrasound and scintigraphy with 99mTc-sestaMIBI are
most frequently used, but their sensitivity and specificity
do not always enable the correct localisation of parathyroid
lesions, especially in cases of multiglandular hyperplasia,
or ectopic glands, or in patients with concomitant thyroid
disease [7].
This fact led to the development of technologies or devices
in order to localise lesions intraoperatively [8, 9]. The recent
introduction of pMGCs enables intraoperative scintigraphic
scanning of parathyroid glands [10, 11], being an alternative
to other intraoperative investigations, such as radioguided
surgery [8] or methylene blue [12], which have been used so
far.
There are few reports in literature about the use of pMGC
in PHP treatment [10, 11].
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In our study, we evaluated the effectiveness of using the
pMGC in a group of patients undergoing parathyroidectomy
for PHP, comparing the results obtained by this method with
the investigation of preoperative localisation (ultrasound and
scintigraphy).
2. Materials and Methods
We analysed data from 20 patients undergoing parathyroid
surgery for PHP in the period between January 2011 andApril
2013.
Demographic features, clinical symptoms of PHP, and
preoperative laboratory tests, with particular reference to
serum calcium and parathyroid hormone (PTH) levels, were
assessed in all these patients. The data obtained on preop-
erative imaging studies (ultrasound of the cervical region
and scintigraphy with 99mTc-sestaMIBI) were recorded in all
patients.
All patients underwent surgery and in all cases the pMGC
IP Guardian 2 (Li-Tech, Rome, Italy) was used.
The pMGC used in the study had the following technical
features:
(i) Detection head of size 7 cm (𝐻) × 7 cm (𝐿) × 27 cm
(𝑃), detection area: 44.1mm × 44.1mm, and weight:
1.2 kg.
(ii) Crystal: Csl(T1) matrix 18 × 18 elements.
(iii) Collimator: tungsten, square holes, and length
24mm.
(iv) Energy resolution: 20% at 141 keV (99mmTc).
(v) Control unit: 10.4-inch screen (1924 × 768), Microsoft
Windows XP Tablet PC Edition operating system;
processor: Intel Centrino Mobile 2MB L2, 1,20GHz;
size: 25.6 cm × 25.6 cm × 2.43 cm (depth); weight:
1.5 kg.
According to the intraoperative image acquisition proto-
col, we intravenously infused 185MBq of 99mTc-sestaMIBI
immediately after the induction of general anaesthesia. Sub-
sequently, the patient was placed on the operating table
and the operating field was prepared, so that enough time
would pass for the isotope to concentrate in the pathological
parathyroid tissue (about 15–20minutes). Scintigraphic scans
were then acquired, positioning the sensing head above the
neck (Figures 1 and 2).
After proper localisation, a minimally invasive parathy-
roidectomy with minicervicotomy was started.
After removing the pathological gland, further images of
the removed material and the operating field were acquired
in order to confirm the radioactivity of the removed material
and the absence of other sources of uptake in the neck.
The levels of ioPTH were recorded in all cases, according
to Miami criteria [13].
We then compared the ability of the preoperative and
intraoperative imaging techniques to correctly locate the
parathyroid lesion not only in terms of right or left laterality,
but also in terms of upper or lower quadrant with respect
to thyroid isthmus. The results provided by the different
Figure 1: Intraoperative scans acquisition.
Figure 2: Lower left adenoma (white arrow).
methods of localisation were compared to the surgical and
pathological findings.
We also recorded the operative times (from skin to skin)
of the patients examined, comparing themwith the operative
time of a homogenous (observation period, number, age, sex,
symptoms, preoperative investigations performed, and sur-
geon) group of patients previously treated surgically without
using the pMGC.
In the long term, all patients were monitored with
clinical outpatient visits and laboratory tests (PTH and serum
calcium) 1, 6, and 12 months after surgery.
3. Results
Of 20 accrued patients, 13 (65%) were females and 7 (35%)
were males.The average age was 63.7 years, with a range from
40 to 80 years (average: 65 years).
No patient was affected by or had a documented family
history of multiple endocrine neoplasia (MEN 1 orMEN 2A).
Clinically 6 patients (30%) were PHP asymptomatic
and 14 (70%) were PHP symptomatic (symptoms shown in
Table 1).
None of the treated patients had a concomitant thyroid
disease, and none had previously undergone surgery on the
cervical region.
Preoperatively, all patients had hypercalcemia with an
average serum calcium of 12.26mg/dL (IC 95%: 11.49–13.03).
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Table 1: Patients with PHP.
Age
Average (IC 95%) 63.7 (58.97–68.43)
Gender
F 13 (65%)
M 7 (35%)
Serum calcium
Average (IC 95%) 12.26mg/dL (11.49–13.03)
PTH
Average (IC 95%) 350.1 pg/mL (233.59–466.61)
Symptoms
No 6 (30%)
Yes 14 (70%)
Kidney 7 (35%)
Osteoarticular 6 (30%)
Neuropsychic 2 (10%)
Digestive 1 (5%)
Acute hypercalcemia 1 (5%)
All cases showed an elevated PTH with a mean value of
350.1 pg/mL (IC 95%: 233.59–466.61) (Table 1).
The data obtained from preoperative imaging studies
(ultrasound and scintigraphy with 99mTc-sestaMIBI), per-
formed in all patients, are depicted in Table 2.
All patients underwent surgery, according to the indica-
tions provided by the latest available guidelines [3] for surgi-
cal treatment of patients with symptomatic or asymptomatic
PHP.
All surgical findings were confirmed by frozen sec-
tion examination at the time of surgery and by definitive
histopathology of the excised tissue. The details of preopera-
tive and intraoperative localisation data, as well as the surgical
and pathologic findings, are given in Tables 2 and 3.
Having considered the results obtained with the ultra-
sound, the preoperative scintigraphy, and the pMGC, we
evaluated the ability of the three methods to properly locate
the pathological glands on the basis of the side and of the
quadrant of the neck. As regards side localisation, neck
ultrasound showed a sensitivity of 95% and a specificity of
100% with a diagnostic accuracy of 99%, a positive predictive
value (PPV) of 100%, and a negative predictive value (NPV) of
98.76%. When considering quadrant localisation, the values
decreased substantially with a sensitivity of 55%, a specificity
of 95%, a diagnostic accuracy of 87%, PPV of 73.33%, and
NPV of 89.41%.
The preoperative scintigraphy with 99mTc-sestaMIBI
showed sensitivity, specificity, diagnostic accuracy, PPV, and
NPV results of 100% with regard to side localisation, whereas
quadrant location showed values of 73.68% and 96.05%,
respectively, for sensitivity and specificity, with a diagnostic
accuracy of 91.58%, PPV of 82.35%, and NPV of 93.59%.
With side localisation the pMGC showed sensitivity,
specificity, diagnostic accuracy, PPV, and NPV values of
100%, while with quadrant localisation it showed sensitivity
and specificity levels of 95% and 98.89%, respectively, a
diagnostic accuracy of 98.18%, PPV of 95%, and NPV of
98.88% (Tables 4 and 5).
In 7 cases (35%) the pMGC gave more accurate informa-
tion than the neck ultrasound and in 5 cases (25%)more than
the preoperative scintigraphic scans.
After removal of parathyroid lesions, MGC scanning
demonstrated no sources of residual radioactivity in the
operating field of any patient.
The ioPTH according to Miami criteria [13] showed a
significant decrease (over 50%) in all patients (100%).
The average operative time was 37.75 minutes (IC 95%):
31.06–44.44 with a median time of 32 minutes. The compar-
ison with a previous group of patients undergoing parathy-
roidectomy showed no significant differences in terms of
average and median duration (39.2 minutes (IC 95%: 28.22–
50.17) and 30 minutes, resp.).
There was no mortality or morbidity in the study group.
Postoperative 3rd-day monitoring of PTH and serum
calcium demonstrated the following mean values: PTH
28.64 pg/mL (IC 95%: 22.48–38.4), with a decrease of
328.29 pg/mL from preoperative data, and serum calcium
9.22mg/dL (IC 95%: 7.64–10.8) with a decrease of 3.69mg/dL
from preoperative data. At the clinical and laboratory follow-
up after 1, 6, and 12 months, no persistent or recurrent PHP
was detected.
4. Discussion
The traditional surgical approach to PHP treatment consisted
of bilateral cervical exploration [14, 15]: this technique led to
a success rate of up to 95%, when performed by dedicated
surgeons [16]. As 85% of PHP cases are supported by a single
parathyroid adenoma [17], minimally invasive surgery was
introduced, with a focal approach to parathyroid lesions,
made possible thanks to the improvements in preoperative
localisation and to the introduction of ioPTH [4].
Themost frequently used preoperative localisationmeth-
ods are neck ultrasound and scintigraphy with 99mTc-
sestaMIBI [18]. The ultrasound has a sensitivity of 76.1%
(range 30%–88%) [19, 20], which reaches a value of 97%
[21], and a specificity of 40% [20] in case of typical cervical
localisation.
The scintigraphy with 99mTc-sestaMIBI provides infor-
mation of functional type [22]. Its sensitivity for detecting
single adenomas varies between 68 and 95%, which decreases
to 44% in case of hyperplasia and 30% in case of double ade-
nomas [18]. The SPECT (Single Photo Emission Computed
Tomography) technique associated with CT (SPECT/CT) is
useful in case of concomitant nodular thyroid disease or
ectopic parathyroid glands (sensitivity over 90%) [23].
The CT and RMN are usually reserved for persistent or
recurrent cases of PHP or ectopic adenomas localisation or
when the ultrasound and the scintigraphy do not identify the
same localisation [24, 25].
Intraoperative localisation techniques have been intro-
duced in order to guide the surgeon during the parathy-
roidectomy, overcoming the limitations of preoperative imag-
ing [12, 26].
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Table 2: Results of preoperative and intraoperative surgical findings and pathological anatomical study locators.
Ultrasound Scintigraphy Portable MGC Surgical findings Anatomy-pathologicalfindings
1 Left Lower left Lower left Lower left Lower left
2 Lower left Lower left Lower left Lower left Lower left
3 Lower left Lower left Lower left Lower left Lower left
4 Right Middle right Upper right Upper right Upper right
5 Middle left Left Upper left Upper left Upper left
6 No injuries Lower left Lower left Lower left Lower left
7 Lower right Right Lower right Lower right Lower right
8 Right Paratracheal right Paratracheal right Paratracheal right Paratracheal right
9 Middle left Left Middle left Upper left Upper left
10 Lower right Lower right Lower right Lower right Lower right
11 Lower right Lower right Lower right Lower right Lower right
12 Lower right Lower right Lower right Lower right Lower right
13 Middle right Lower right Lower right Lower right Lower right
14 Middle left Lower left Lower left Lower left Lower left
15 Upper left Upper left Upper left Upper left Upper left
16 Right Upper left Upper right Upper right Upper right
17 Lower left Middle left Lower left Lower left Lower left
18 Lower right Lower right Lower right Lower right Lower right
19 Upper left Upper left Upper left Upper left Upper left
20 Upper left Middle left Upper left Upper left Upper left
Table 3: Surgical findings.
Lower left adenoma 6 (30%)
Lower right adenoma 6 (30%)
Upper left adenoma 5 (25%)
Upper right adenoma 2 (10%)
Ectopic adenoma 1 (5%) paratracheal right
Table 4: Sensitivity, specificity, diagnostic accuracy, PPV, and NPV
of the localisation investigations used according to the side of the
neck.
Sensitivity Specificity Diagnosticaccuracy PPV NPV
Ultrasound 95% 100% 99% 100% 98.76%
Preoperative
scintigraphy 100% 100% 100% 100% 100%
pMGC 100% 100% 100% 100% 100%
In 1971 Dudley [12] was the first to report the intra-
operative use of methylene blue: this method, however,
has limitations, arising from the fact that even the normal
parathyroid glands may be discoloured, just like thyroid
nodules and lymph nodes [9].
The use of a gamma probe is the basis of minimally
invasive radioguided parathyroidectomy (MIRP), proposed
for the first time by Norman and Chheda in 1997 [26].
Table 5: Sensitivity, specificity, diagnostic accuracy, PPV, and NPV
of the localisation used according to the quadrant of the neck.
Sensitivity Specificity Diagnostic
accuracy
PPV NPV
Ultrasound 55% 95% 87% 73.33% 89.41%
Preoperative
scintigraphy
73.68% 96.05% 91.58% 82.35% 93.59%
pMGC 95% 98.89% 98.18% 95% 98.88%
The use of gamma probes allows the detection of sources
of radiotracers administered at the time of induction of
anaesthesia [27].
Gamma probes, however, translate focus intensity into
count rate and audio signalling and as such do not guarantee
the more precise localisation given by imaging [28].
A further improvement was provided by the introduction
of the pMGC, small in size and lightweight, which can
provide scintigraphic images during surgery [10, 29, 30]. The
use of the pMGC involves 99mTc-sestaMIBI being injected
before surgery and the acquisition of scans before the lesion
is removed, in order to locate the lesion itself, and also after
it has been removed, to confirm the excision of the whole
pathological tissue, along with the scanning of the specimens
[10]. The first clinical application of this method appeared in
2007 [10].
The pMGC presented high levels of sensitivity and
specificity, higher than those of the preoperative ultrasound
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and scintigraphy [10, 11], and appears to be useful in cases
of concomitant thyroid disease and in cases with negative
preoperative studies [11].
Estrems and colleagues [11] evaluated the feasibility of
this method in a group of 29 patients: side localisation with
pMGC showed a sensitivity of 86.6% and a specificity of
90.9% compared to the 79.3% and 92.5%, respectively, of
preoperative investigations (ultrasound + scintigraphy) while
quadrant localisation showed a sensitivity of 83.3% and a
specificity of 90.9%, when compared to 48.35% and 72.7%,
respectively, reported in the preoperative surveys.
In our experience the pMGCproperly localised all lesions
by side (diagnostic accuracy 100%)with both a sensitivity and
a specificity of 100%, while as far as quadrant was considered
pMGC showed a diagnostic accuracy of 98.1%, a sensitivity of
95.0%, and a specificity of 98.8% (Tables 4 and 5).
In particular, its use guaranteed a more precise localisa-
tion of lesions in 7 cases (35%) with respect to ultrasound
scan and in 5 cases (25%) with respect to scintigraphy with
99mTc-sestaMIBI. The data obtained from our experience are
comparable to those reported previously [10, 11, 31].
This technology appears to be a potential alternative
to ioPTH measurement allowing obtaining and comparing
easy-to-read images before and after excision of the parathy-
roid lesions [31, 32].The absence of radiotracer uptake sources
in the postexcision images confirms the completeness of the
parathyroidectomy, completeness that is usually confirmed
by the significant fall in PTH, also.
Despite the limited number of patients studied, our
study has confirmed the possibility of replacing the ioPTH
measurement with the intraoperative use of the pMGC,
because in all cases the images obtained after removal of
the 12 parathyroid lesions were comparable to the fall in
ioPTH levels. The pMGC may also be a possible alternative
to preoperative scintigraphy with 99mTc-sestaMIBI.
As far as operative time is concerned, there was no
statistical difference between the duration of the mini-
invasive radioguided parathyroidectomywith pMGC and the
duration of a parathyroidectomy guided only by preoperative
studies (𝑝 > 0.05). This may lead to the inference that the
additional time used to acquire the images was offset by the
easier retrieval of surgical lesions, made possible by the more
precise information provided by the pMGC.
5. Conclusions
We believe that the pMGC may be used as an intraoperative
method to locate the correct position of the pathological
parathyroid glands. The pMGC is more reliable than the
preoperative and intraoperative localisation techniques used
so far. Our study has also confirmed that the pMGC could
replace the ioPTH measuring, by comparing the images
obtained before and after the excision of the parathyroid
lesions.
Conflict of Interests
The authors declare no conflict of interests regarding the
publication of this paper.
References
[1] B. C. Stack Jr., “Minimally invasive radioguided parathyroidec-
tomy,”Operative Techniques in Otolaryngology, vol. 20, no. 1, pp.
54–59, 2009.
[2] R. Mihai, D. Simon, and P. Hellman, “Imaging for pri-
mary hyperparathyroidism–an evidence-based analysis,” Lan-
genbeck’s Archives of Surgery, vol. 394, no. 5, pp. 765–784, 2009.
[3] J. P. Bilezikian, A. A. Khan, and J. T. Potts Jr., “On behalf of the
Third International Workshop on the Management of Asymp-
tomatic Primary Hyperparathyroidism. Guidelines for the
management of asymptomatic primary hyperparathyroidism:
summary statement from the third international workshop,”
The Journal of Clinical Endocrinology &Metabolism, vol. 94, pp.
335–339, 2009.
[4] K. Lorenz, P. Nguyen-Thanh, and H. Dralle, “Unilateral open
and minimally invasive procedures for primary hyperparathy-
roidism: a review of selective approaches,” Langenbeck’s Archives
of Surgery, vol. 385, no. 2, pp. 106–117, 2000.
[5] P. Miccoli, P. Berti, G. Materazzi, C. E. Ambrosini, L. Fre-
goli, and G. Donatini, “Endoscopic bilateral neck exploration
versus quick intraoperative parathormone assay (qPTHa) dur-
ing endoscopic parathyroidectomy: a prospective randomized
trial,” Surgical Endoscopy and Other Interventional Techniques,
vol. 22, no. 2, pp. 398–400, 2008.
[6] D. Rubello, D. Casara, and M. R. Pelizzo, “Symposium on
parathyroid localization. Optimization of peroperative proce-
dures,” Nuclear Medicine Communications, vol. 24, no. 2, pp.
133–140, 2003.
[7] C. D. Phillips and D. R. Shatzkes, “Imaging of the parathyroid
glands,” Seminars in Ultrasound, CT and MRI, vol. 33, no. 2, pp.
123–129, 2012.
[8] M. Shabtai, M. Ben-Haim, Y. Muntz et al., “140 Consecutive
cases of minimally invasive, radio-guided parathyroidectomy:
lessons learned and long-term results,” Surgical Endoscopy and
Other Interventional Techniques, vol. 17, no. 5, pp. 688–691, 2003.
[9] D. B. Kuriloff and K. V. Sanborn, “Rapid intraoperative local-
ization of parathyroid glands utilizingmethylene blue infusion,”
Otolaryngology—Head andNeck Surgery, vol. 131, no. 5, pp. 616–
622, 2004.
[10] J. Ortega, J. Ferrer-Rebolleda, N. Cassinello, and S. Lledo,
“Potential role of a new hand-held miniature gamma camera in
performing minimally invasive parathyroidectomy,” European
Journal of Nuclear Medicine and Molecular Imaging, vol. 34, no.
2, pp. 165–169, 2007.
[11] P. Estrems, F. Guallart, P. Abreu, P. Sopena, J. Dalmau, and
R. Sopena, “The intraoperative mini gamma camera in pri-
mary hyperparathyroidism surgery,”Acta Otorrinolaringologica
Espanola, vol. 63, no. 6, pp. 450–457, 2012.
[12] N. E. Dudley, “Methylene blue for rapid identification of the
parathyroids,” British Medical Journal, vol. 3, no. 776, pp. 680–
681, 1971.
[13] M. Barczynski, A. Konturek, A. Hubalewska-Dydejczyk, S.
Cichon, andW.Nowak, “Evaluation ofHalle,Miami, Rome, and
Vienna intraoperative iPTH assay criteria in guiding minimally
invasive parathyroidectomy,” Langenbeck’s Archives of Surgery,
vol. 394, no. 5, pp. 843–849, 2009.
[14] Consensus Development Conference Panel, “Diagnosis and
management of asymptomatic primary hyperparathyroidism:
consensus development conference statement,” Annals of Inter-
nal Medicine, vol. 114, no. 7, pp. 593–597, 1991.
6 International Journal of Endocrinology
[15] J. L. Doppman, “Preoperative localization of parathyroid tissue
in primary hyperparathyroidism,” in The Parathyroids, p. 475,
Academic Press, San Diego, Calif, USA, 2nd edition, 2001.
[16] R. Harris, H. Ryu, T. Vu et al., “Modern approach to surgical
intervention of the thyroid and parathyroid glands,” Seminars
in Ultrasound, CT and MRI, vol. 33, no. 2, pp. 115–122, 2012.
[17] W. D. Fraser, “Hyperparathyroidism,” The Lancet, vol. 374, no.
9684, pp. 145–158, 2009.
[18] N. A. Johnson, S. E. Carty, and M. E. Tublin, “Parathyroid
imaging,” Radiologic Clinics of North America, vol. 49, no. 3, pp.
489–509, 2011.
[19] C. C. Solorzano, D. M. Carneiro-Pla, and G. L. Irvin III, “Sur-
geon-performed ultrasonography as the initial and only local-
izing study in sporadic primary hyperparathyroidism,” Journal
of the American College of Surgeons, vol. 202, no. 1, pp. 18–24,
2006.
[20] B. J. Ammori, M. Madan, T. D. Gopichandran et al., “Ultra-
sound-guided unilateral neck exploration for sporadic primary
hyperparathyroidism: is it worthwhile?” Annals of the Royal
College of Surgeons of England, vol. 80, no. 6, pp. 433–437, 1998.
[21] D. Hajioff, T. Iyngkaran, C. Panagamuwa, D. Hill, and M. P.
Stearns, “Preoperative localization of parathyroid adenomas:
ultrasonography, sestamibi scintigraphy, or both?”Clinical Oto-
laryngology & Allied Sciences, vol. 29, no. 5, pp. 549–552, 2004.
[22] D. Rubello, G. Mariani, and M. R. Pelizzo, “Minimally invasive
radio-guided parathyroidectomy on a group of 452 primary
hyperparathyroid patients,” NuklearMedizin, vol. 46, no. 3, pp.
85–92, 2007.
[23] S. Hassler, D. Ben-Sellem, F. Hubele, A. Constantinesco, and
C. Goetz, “Dual-isotope 99mTc-MIBI/123I parathyroid scintig-
raphy in primary hyperparathyroidism: comparison of sub-
traction SPECT/CT and pinhole planar scan,” Clinical Nuclear
Medicine, vol. 39, no. 1, pp. 32–36, 2014.
[24] N. D. Gross, J. L. Weissman, E. Veenker, and J. I. Cohen, “The
diagnostic utility of computed tomography for preoperative
localization in surgery for hyperparathyroidism,” Laryngoscope,
vol. 114, no. 2, pp. 227–231, 2004.
[25] E. L. Ha¨nninen, T. J. Vogl, T. Steinmu¨ller, J. Ricke, P. Neuhaus,
and R. Felix, “Preoperative contrast-enhanced MRI of the
parathyroid glands in hyperparathyroidism,” Investigative Radi-
ology, vol. 35, no. 7, pp. 426–430, 2000.
[26] J. Norman and H. Chheda, “Minimally invasive parathyroidec-
tomy facilitated by intraoperative nuclear mapping,” Surgery,
vol. 122, no. 6, pp. 998–1004, 1997.
[27] D. Rubello, A. Al-Nahhas, G. Mariani, M. D. Gross, L. Rampin,
and M. R. Pelizzo, “Feasibility and long-term results of focused
radioguided parathyroidectomy using a ‘low’ 37 MBq (1mCi)
99mTc-sestamibi protocol,” International Seminars in Surgical
Oncology, vol. 3, article 30, 2006.
[28] M. Tsuchimochi and K. Hayama, “Intraoperative gamma cam-
eras for radioguided surgery: technical characteristics, perfor-
mance parameters, and clinical applications,” Physica Medica,
vol. 29, no. 2, pp. 126–138, 2013.
[29] L. Menard, Y. Charon, M. Solal et al., “POCI: a compact high
resolution 𝛾 camera for intra-operative surgical use,” IEEE
Transactions on Nuclear Science, vol. 45, no. 3, pp. 1293–1297,
1998.
[30] A. Ferretti, S. Chondrogiannis, A. Marcolongo, and D. Rubello,
“Phantom study of a new hand-held 𝛾-imaging probe for radio-
guided surgery,”Nuclear Medicine Communications, vol. 34, no.
1, pp. 86–90, 2013.
[31] N. Cassinello, J. Ortega, and S. Lledo, “Intraoperative real-time
99mTc-sestamibi scintigraphy with miniature gamma camera
allows minimally invasive parathyroidectomy without ioPTH
determination in primary hyperparathyroidism,” Langenbeck’s
Archives of Surgery, vol. 394, no. 5, pp. 869–874, 2009.
[32] T. Fujii, R. Yajima, S. Yamaguchi, S. Tsutsumi, T. Asao, and
H. Kuwano, “Could the eZ-SCOPE AN gamma camera replace
intraoperative measurement of iPTH for PHPT?” International
Surgery, vol. 97, no. 2, pp. 99–103, 2012.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
